|
|
||||||||
Animal: RNA Viruses |
Institute for Animal Health, Pirbright Laboratory, Pirbright, Surrey GU24 0NF, UK1
INRA Virology et Immunologie moléculaires, INRA, 78350 Jouy-en-josas, France2
Author for correspondence: Leticia Cedillo-Barrón. Present address: Centro de Investigacion y de Estudios Avanzados del IPN, Departamento de Biomedicina Molecular, Av. IPN #2508 Col. Zacatenco, 07360 México DF. Fax +52 5 747 7134. e-mail lcedillo{at}mail.cinvestav.mx
This work focuses on the development of a potential recombinant DNA vaccine against foot-and-mouth disease virus (FMDV). Such a vaccine would have significant advantages over the conventional inactivated virus vaccine, in particular having none of the risks associated with the high security requirements for working with live virus. The principal aim of this strategy was to stimulate an antibody response to native, neutralizing epitopes of empty FMDV capsids generated in vivo. Thus, a plasmid (pcDNA3.1/P12A3C3D) was constructed containing FMDV cDNA sequences encoding the viral structural protein precursor P12A and the non-structural proteins 3C and 3D. The 3C protein was included to ensure cleavage of the P12A precursor to VP0, VP1 and VP3, the components of self-assembling empty capsids. The non-structural protein 3D was also included in the construct in order to provide additional stimulation of CD4+ T cells. When swine were immunized with this plasmid, antibodies to FMDV and the 3D polymerase were synthesized. Furthermore, neutralizing antibodies were detected and, after three sequential vaccinations with DNA, some of the animals were protected against challenge with live virus. Additional experiments suggested that the antibody response to FMDV proteins was improved by the co-administration of a plasmid encoding porcine granulocytemacrophage colony-stimulating factor. Although still not as effective as the conventional virus vaccine, the results encourage further work towards the development of a DNA vaccine against FMDV.
This article has been cited by other articles:
![]() |
M. Rodriguez Pulido, F. Sobrino, B. Borrego, and M. Saiz Attenuated Foot-and-Mouth Disease Virus RNA Carrying a Deletion in the 3' Noncoding Region Can Elicit Immunity in Swine J. Virol., April 15, 2009; 83(8): 3475 - 3485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Moraes, T. de los Santos, M. Koster, T. Turecek, H. Wang, V. G. Andreyev, and M. J. Grubman Enhanced Antiviral Activity against Foot-and-Mouth Disease Virus by a Combination of Type I and II Porcine Interferons J. Virol., July 1, 2007; 81(13): 7124 - 7135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Grubman and B. Baxt Foot-and-Mouth Disease Clin. Microbiol. Rev., April 1, 2004; 17(2): 465 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Kollnberger, B. Gutierrez-Castaneda, M. Foster-Cuevas, A. Corteyn, and R. M. E. Parkhouse Identification of the principal serological immunodeterminants of African swine fever virus by screening a virus cDNA library with antibody J. Gen. Virol., April 1, 2002; 83(6): 1331 - 1342. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |